Corpus Intelligence IC Memo — HARSHA BEHAVIORAL CENTER 2026-04-26 08:09 UTC
IC Memo — HARSHA BEHAVIORAL CENTER
Investment Committee Memorandum | IN | 81 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HARSHA BEHAVIORAL CENTER

CCN 154054 | VIGO, IN | 81 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HARSHA BEHAVIORAL CENTER is a 81-bed suburban community hospital in VIGO, IN with $14.3M in net patient revenue and a 9.0% operating margin. The hospital serves a payer mix of 15.9% Medicare, 15.8% Medicaid, and 68.3% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.0% to 16.4% (+737bps).

Net Revenue HCRIS$14.3M
Current EBITDA COMPUTED$1.3M
Operating Margin COMPUTED9.0%
Occupancy HCRIS49.6%
Revenue / Bed COMPUTED$177K
Net-to-Gross HCRIS68.2%
Distress Probability ML56.3%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
65
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 9.0% places it above the state median. Among 65 size-comparable peers (40-162 beds), the median margin is 1.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-162), prioritizing same-state peers. 65 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HARSHA BEHAVIORAL CENTER (Target)IN81$14.3M9.0%
HENDRICKS REGIONAL HEALTHIN130$423.4M-3.6%
IU HEALTH NORTH HOSPITALIN153$413.3M24.2%
FRANCISCAN HEALTH MICHIGAN CITIN119$276.7M6.1%
ASCENSION ST. VINCENT CARMELIN124$268.5M38.3%
MEMORIAL HOSP & HEALTH CARE CTIN96$259.1M28.7%
GOSHEN HOSPITALIN103$248.4M-22.8%
RIVERVIEW HOSPITALIN121$233.1M-19.0%
GOOD SAMARITAN HOSPITALIN99$233.1M-12.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$300K+210bp18mo
Cost to Collect4.5%2.5%$286K+200bp12mo
Denial Rate Reduction12.0%6.5%$283K+198bp12mo
A/R Days Reduction5200.0%3800.0%$174K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$300K
Cost to Collect
$286K
Denial Rate Reduction
$283K
A/R Days Reduction
$174K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$1.3M
+ RCM Uplift+$1.1M
Pro Forma EBITDA$2.3M
Current Margin9.0%
Pro Forma Margin16.4%
WC Released (1x)$548K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.0M$19.0M9.60x57.2%
Base (11x exit)10.0x11.0x$2.0M$21.6M10.88x61.2%
Bull Case9.0x11.0x$1.8M$25.7M14.40x70.5%
Bull (12x exit)9.0x12.0x$1.8M$28.6M16.01x74.1%
Bear Case11.0x10.0x$2.2M$13.1M6.02x43.2%
Bear (11x exit)11.0x11.0x$2.2M$15.1M6.94x47.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 56.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 65 hospitals with 40-162 beds
  • Same-state prioritization (n=66)
  • Comp margins: P25=-11.7% / P50=1.3% / P75=18.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.